ETC
PGEN icon

Exchange Traded Concepts’s Precigen PGEN Stock Holding History

Exchange Traded Concepts’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-71,566
Closed -$107K – 1481
2025
Q1 		$107K Sell
71,566
-95,930
-57% -$151K ﹤0.01% 1139
2024
Q4 		$188K Hold
167,496
– – ﹤0.01% 1008
2024
Q3 		$159K Buy
167,496
+15,525
+10% +$19.6K ﹤0.01% 1047
2024
Q2 		$240K Sell
151,971
-47,284
-24% -$68.7K 0.01% 853
2024
Q1 		$289K Buy
199,255
+105,164
+112% +$151K 0.01% 813
2023
Q4 		$126K Buy
94,091
+23,859
+34% +$28K ﹤0.01% 856
2023
Q3 		$99.7K Sell
70,232
-37,453
-35% -$53.1K ﹤0.01% 898
2023
Q2 		$124K Buy
+107,685
New +$127K ﹤0.01% 900
2020
Q4 		– Sell
-218
Closed -$1K – 1126
2020
Q3 		$1K Buy
+218
New +$1.03K ﹤0.01% 883

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Exchange Traded Concepts's PGEN Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Precigen (PGEN) in Q2 2025, closing a stake of 71,566 shares — an estimated $107K sold.

Exchange Traded Concepts first reported a position in PGEN in Q3 2020 and held it in 9 quarters. The position peaked at $289K in Q1 2024. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 71,566 Precigen shares in Q2 2025, an estimated $107K.
  • Exchange Traded Concepts first reported a position in Precigen in Q3 2020 and held it in 9 quarters.
  • Exchange Traded Concepts's Precigen position peaked at $289K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.